MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Nature Reviews Clinical Oncology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

128 results · 1 filter active ·
Results by year
20092025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
128 works in the cohort · of 4,299,418page 2 of 3

Labels cover 0 of 128 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 128 of 128 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

fundno affno abstractunlabeled
The potential of exploiting DNA-repair defects for optimizing lung cancer treatment
Sophie Postel‐Vinay, Elsa Vanhecke, Ken A. Olaussen, Christopher J. Lord, Alan Ashworth, Jean‐Charles Soria
2012· review· en· Nature Reviews Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
111
citations
afffundno abstractunlabeled
Beneficial autoimmunity improves cancer prognosis
Laurence Zitvogel, Claude Perreault, Olivera J. Finn, Guido Kroemer
2021· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · research_integrity
106
citations
affno abstractunlabeled
Informative censoring — a neglected cause of bias in oncology trials
Arnoud J. Templeton, Eitan Amir, Ian F. Tannock
2020· review· en· Nature Reviews Clinical Oncology· Mathematics
distilled prediction:candidate · metaresearch+metaepi_narrow+metaepi_broad+research_integrityconsensus · metaresearch+metaepi_narrow+research_integrity
96
citations
affno abstractunlabeled
Targeting ATR in patients with cancer
Natalie Y.L. Ngoi, Patrick G. Pilié, Daniel J. McGrail, Michal Zimmermann, Katharina Schlacher, Timothy A. Yap
2024· review· en· Nature Reviews Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
87
citations
affno abstractunlabeled
Bilateral breast cancers
Steven A. Narod
2014· review· en· Nature Reviews Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
72
citations
afffundno abstractunlabeled
The paradox of precision medicine
Jonathan Kimmelman, Ian F. Tannock
2018· review· en· Nature Reviews Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaresearch+research_integrityconsensus · none
64
citations
affno abstractunlabeled
Synthetic lethal strategies for the development of cancer therapeutics
Natalie Y.L. Ngoi, David Gallo, Mirella Nardo, Daniel Durocher, Timothy A. Yap
2024· review· en· Nature Reviews Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · research_integrityconsensus · none
61
citations
fundno affno abstractunlabeled
Vessel calibre—a potential MRI biomarker of tumour response in clinical trials
Kyrre E. Emblem, Christian T. Farrar, Elizabeth R. Gerstner, Tracy T. Batchelor, Ronald Borra, Bruce R. Rosen +1 more
2014· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+metaepi_broad+research_integrityconsensus · metaresearch+metaepi_broad+research_integrity
59
citations
affno abstractunlabeled
Real-world evidence and regulatory drug approval
Michael J. Raphael, Bishal Gyawali, Christopher M. Booth
2020· review· en· Nature Reviews Clinical Oncology· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · research_integrity
49
citations
afffundno abstractunlabeled
Imatinib and the long tail of targeted drug development
Benjamin Gregory Carlisle, Tiger Zheng, Jonathan Kimmelman
2019· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
39
citations
afffundno abstractunlabeled
COVID-19 and cancer: do we really know what we think we know?
Andrew Robinson, Bishal Gyawali, Gerald A. Evans
2020· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+metaepi_broad+research_integrity+insufficient_payloadconsensus · metaepi_narrow+research_integrity
38
citations
afffundno abstractunlabeled
Management of familial cancer: sequencing, surveillance and society
Nardin Samuel, Anita Villani, Conrad V. Fernandez, David Malkin
2014· review· en· Nature Reviews Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
36
citations
affno abstractunlabeled
Rationale for metronomic chemotherapy in phase III trials
Robert S. Kerbel, Axel Grothey
2015· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+metaepi_broad+research_integrityconsensus · none
27
citations
affno abstractunlabeled
Leptomeningeal metastatic disease: new frontiers and future directions
Ahmad Ozair, Hannah Wilding, Debarati Bhanja, Nicholas Mikolajewicz, Michael Glantz, Stuart A. Grossman +17 more
2024· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
25
citations
affno abstractunlabeled
Two decades of advances in clinical oncology — lessons learned and future directions
Susana Banerjee, Christopher M. Booth, Éduardo Bruera, Markus W. Büchler, Alexander Drilon, Terry J. Fry +12 more
2024· review· en· Nature Reviews Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
22
citations
affno abstractunlabeled
Unintended pregnancy during radiotherapy for cancer
Saskia N. de Wildt, Nobuko Taguchi, Gideon Koren
2009· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
18
citations
affno abstractunlabeled
Infant medulloblastoma — learning new lessons from old strata
Marc Remke, Vijay Ramaswamy
2018· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+research_integrity+insufficient_payloadconsensus · research_integrity+insufficient_payload
18
citations
affno abstractunlabeled
Problematic crossovers in cancer drug trials
Bishal Gyawali
2023· review· en· Nature Reviews Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaresearch+metaepi_narrow+research_integrityconsensus · research_integrity
16
citations
affno abstractunlabeled
Should the control arms of randomized trials have an expiry date?
Adi Kartolo, Bishal Gyawali
2022· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+metaepi_broad+research_integrity+insufficient_payloadconsensus · metaresearch+research_integrity
11
citations
affno abstractunlabeled
Zoledronic acid for breast cancer therapy-induced bone loss
Eitan Amir, Alberto Ocaña, Boštjan Šeruga, Robert G. Josse, Mark Clemons
2010· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
10
citations
affno abstractunlabeled
Publisher Correction: The adenosine pathway in immuno-oncology
Bertrand Allard, David Allard, Laurence Buisseret, John Stagg
2020· review· en· Nature Reviews Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
9
citations
affno abstractunlabeled
Why patients receive treatments that are minimally effective?
Christopher M. Booth, Allan S. Detsky
2018· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · metaepi_narrow+research_integrity+insufficient_payload
9
citations
affno abstractunlabeled
Cetuximab, chemotherapy and KRAS status in mCRC
Sharlene Gill, Richard M. Goldberg
2009· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
8
citations

How this was built: Screen · Findings · About